Home » Stocks » ARA

American Renal Associates Holdings Inc. (ARA)

Jan 25, 2021 - ARA was delisted (reason: acquired by Innovative Renal Care)
Stock Price: $11.50 USD 0.00 (0.00%)
Updated Jan 22, 2021 4:00 PM EST
Market Cap 397.94M
Revenue (ttm) 814.10M
Net Income (ttm) -16.86M
Shares Out 33.47M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Jan 22, 2021
Last Price $11.50
Previous Close $11.50
Change ($) 0.00
Change (%) 0.00%
Day's Open 11.48
Day's Range 11.33 - 11.52
Day's Volume 9,831
52-Week Range 5.78 - 11.79

News

Hide News
Business Wire - 1 month ago

BEVERLY, Mass.--(BUSINESS WIRE)--Nautic Partners and its portfolio company, Innovative Renal Care (IRC), have completed the previously announced transaction to acquire American Renal Associate...

PRNewsWire - 2 months ago

NEW YORK, Dec. 17, 2020 /PRNewswire/ -- American Renal Associates Holdings, Inc. (NYSE: ARA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connect...

PRNewsWire - 3 months ago

NEW YORK, Nov. 25, 2020 /PRNewswire/ -- American Renal Associates Holdings, Inc. (NYSE: ARA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connect...

Zacks Investment Research - 3 months ago

American Renal Associates (ARA) delivered earnings and revenue surprises of -214.29% and -0.86%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahea...

PRNewsWire - 3 months ago

NEW YORK, Nov. 6, 2020 /PRNewswire/ -- American Renal Associates Holdings, Inc. (NYSE: ARA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connecti...

Business Wire - 3 months ago

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologist...

PRNewsWire - 4 months ago

NEW YORK, Oct. 23, 2020 /PRNewswire/ -- American Renal Associates Holdings, Inc. (NYSE: ARA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connect...

Business Wire - 4 months ago

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of American...

PRNewsWire - 4 months ago

NEW YORK, Oct. 9, 2020 /PRNewswire/ -- American Renal Associates Holdings, Inc. (NYSE: ARA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connecti...

Business Wire - 4 months ago

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of American Renal Associates Holdings, Inc. (NYSE: ARA) to Innovative Renal Ca...

Newsfile Corp - 4 months ago

New York, New York--(Newsfile Corp. - October 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased American Renal Associates Ho...

PRNewsWire - 4 months ago

MILWAUKEE, Oct. 2, 2020 /PRNewswire/ -- Ademi LLP is investigating American Renal Associates (NYSE: ARA) for possible breaches of fiduciary duty and other violations of the law in its transact...

Business Wire - 4 months ago

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that it has ...

Business Wire - 5 months ago

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Compa...

Seeking Alpha - 6 months ago

American Renal Associates Holdings, Inc. (ARA) CEO Joe Carlucci on Q2 2020 Results - Earnings Call Transcript

Business Wire - 6 months ago

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc.

Business Wire - 6 months ago

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc.

Zacks Investment Research - 9 months ago

American Renal Associates (ARA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Seeking Alpha - 9 months ago

American Renal Associates Holdings, Inc. (ARA) CEO Joe Carlucci on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 11 months ago

American Renal Associates (ARA) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Seeking Alpha - 11 months ago

American Renal Associates Holdings, Inc. (ARA) CEO Joseph Carlucci on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

American Renal Associates Holdings, Inc. (ARA) CEO Joseph Carlucci on Q3 2019 Results - Earnings Call Transcript

Market Watch - 1 year ago

Shares of DaVita Inc. bounced 4.3% in afternoon trading Wednesday, after President Trump signed an executive order on kidney disease, aimed at cutting costs of dialysis treatments.

Other stocks mentioned: DVA
Seeking Alpha - 1 year ago

Shares have completed a daily low.

The Motley Fool - 1 year ago

Traders flee after the company announces that its CFO has resigned and that some of its financial statements need to be restated. Here's what investors need to know.

Market Watch - 1 year ago

Shares of American Renal Associates Holdings Inc. plunged 38% Thursday morning.

About ARA

American Renal Associates Holdings operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Bev... [Read more...]

Industry
Diagnostics & Research
IPO Date
Apr 21, 2016
CEO
Joseph Carlucci
Employees
4,977
Stock Exchange
NYSE
Ticker Symbol
ARA
Full Company Profile

Financial Performance

In 2019, ARA's revenue was $822.52 million, an increase of 2.08% compared to the previous year's $805.78 million. Losses were -$13.79 million, -52.06% less than in 2018.

Financial Statements